TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Avia Pharma AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
206,779
|
227,600
|
205,507 |
| Financial expenses |
77,339
|
39,333
|
28,795 |
| Earnings before taxes |
-15,519
|
-10,038
|
18,052 |
| EBITDA |
8,308
|
12,769
|
29,320 |
| Total assets |
803,233
|
504,455
|
475,900 |
| Current assets |
115,391
|
114,994
|
118,181 |
| Current liabilities |
47,117
|
50,200
|
56,444 |
| Equity capital |
162,864
|
89,180
|
64,770 |
| - share capital |
309
|
304
|
284 |
| Employees (average) |
11
|
8
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
20.3%
|
17.7%
|
13.6% |
| Turnover per employee |
18,798
|
28,450
|
29,358 |
| Profit as a percentage of turnover |
-7.5%
|
-4.4%
|
8.8% |
| Return on assets (ROA) |
7.7%
|
5.8%
|
9.8% |
| Current ratio |
244.9%
|
229.1%
|
209.4% |
| Return on equity (ROE) |
-9.5%
|
-11.3%
|
27.9% |
| Change turnover |
-24,924
|
7,511
|
17,997 |
| Change turnover % |
-11%
|
3%
|
10% |
| Chg. No. of employees |
3
|
1
|
1 |
| Chg. No. of employees % |
38%
|
14%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.